Antibody and T Cell Reactivity Response After SARS-CoV-2 BNT162b2 mRNA Vaccine in Hemodialysis Patients: A Single-Center Experience from Sweden

被引：0
|
作者：
Melin, Jan [1 ,2 ]
Svensson, Maria K. [1 ,2 ]
Albinsson, Bo [1 ,2 ]
Pauksens, Karlis [1 ,2 ]
机构：
[1] Akad Sjukhuset, Uppsala, Sweden
[2] Uppsala Univ, Uppsala, Sweden
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PO0127
引用
收藏
页码：94 / 94
页数：1
相关论文
共 50 条
  • [21] Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients
    Attias, Philippe
    Sakhi, Hamza
    Rieu, Philippe
    Soorkia, Arvish
    Assayag, David
    Bouhroum, Sabrina
    Nizard, Patrice
    El Karoui, Khalil
    KIDNEY INTERNATIONAL, 2021, 99 (06) : 1490 - 1492
  • [22] Humoral Response after Three Doses of mRNA-1273 or BNT162b2 SARS-CoV-2 Vaccines in Hemodialysis Patients
    Jesus Broseta, Jose
    Rodriguez-Espinosa, Diana
    Cuadrado, Elena
    Rodriguez, Nestor
    Luis Bedini, Jose
    Maduell, Francisco
    VACCINES, 2022, 10 (04)
  • [23] Humoral Response to BNT162b2 mRNA SARS-CoV-2 Vaccine in Patients with Nondialysis Chronic Kidney Disease
    Kervella, Delphine
    Braud, Pierre
    Garandeau, Claire
    Phelizot, Celine
    Ambrosi, Xavier
    Blancho, Gilles
    Hourmant, Maryvonne
    Figueres, Lucile
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (12): : 1872 - 1874
  • [24] Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection
    Gobbi, Federico
    Buonfrate, Dora
    Moro, Lucia
    Rodari, Paola
    Piubelli, Chiara
    Caldrer, Sara
    Riccetti, Silvia
    Sinigaglia, Alessandro
    Barzon, Luisa
    VIRUSES-BASEL, 2021, 13 (03):
  • [25] Predictors of humoral response to SARS-CoV-2 mRNA vaccine BNT162b2 in patients receiving maintenance dialysis
    Li, Tingting
    Gandra, Sumanth
    Reske, Kimberly A.
    Olsen, Margaret A.
    Bommarito, Silvana
    Miller, Candace
    Hock, Karl G.
    Ballman, Claire A.
    Su, Christina
    Le Dang, Na
    Kwon, Jennie H.
    Warren, David K.
    Fraser, Victoria J.
    Farnsworth, Christopher W.
    ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2022, 2 (01):
  • [26] The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients
    Zitt, Emanuel
    Davidovic, Tamara
    Schimpf, Judith
    Abbassi-Nik, Armin
    Mutschlechner, Beatrix
    Ulmer, Hanno
    Benda, Magdalena A.
    Sprenger-Maehr, Hannelore
    Winder, Thomas
    Lhotta, Karl
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [27] Impaired Functional T-Cell Response to SARS-CoV-2 After Two Doses of BNT162b2 mRNA Vaccine in Older People
    Demaret, Julie
    Corroyer-Simovic, Benedicte
    Alidjinou, Enagnon Kazali
    Goffard, Anne
    Trauet, Jacques
    Miczek, Sophie
    Vuotto, Fanny
    Dendooven, Arnaud
    Huvent-Grelle, Dominique
    Podvin, Juliette
    Dreuil, Daniel
    Faure, Karine
    Deplanque, Dominique
    Bocket, Laurence
    Duhamel, Alain
    Labreuche, Julien
    Sobaszek, Annie
    Hisbergues, Michael
    Puisieux, Francois
    Labalette, Myriam
    Lefevre, Guillaume
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [28] B Cell Response Induced by SARS-CoV-2 Infection Is Boosted by the BNT162b2 Vaccine in Primary Antibody Deficiencies
    Pulvirenti, Federica
    Fernandez Salinas, Ane
    Milito, Cinzia
    Terreri, Sara
    Piano Mortari, Eva
    Quintarelli, Concetta
    Di Cecca, Stefano
    Lagnese, Gianluca
    Punziano, Alessandra
    Guercio, Marika
    Bonanni, Livia
    Auria, Stefania
    Villani, Francesca
    Albano, Christian
    Locatelli, Franco
    Spadaro, Giuseppe
    Carsetti, Rita
    Quinti, Isabella
    CELLS, 2021, 10 (11)
  • [29] Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2)
    Favresse, Julien
    Bayart, Jean-Louis
    Mullier, Francois
    Dogne, Jean-Michel
    Closset, Melanie
    Douxfils, Jonathan
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (09) : 1351.e5 - 1351.e7
  • [30] Antibody titres before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients with cancer
    Debie, Yana
    Vandamme, Timon
    Goossens, Maria E.
    van Dam, Peter A.
    Peeters, Marc
    EUROPEAN JOURNAL OF CANCER, 2022, 163 : 177 - 179
12345